AMP-activated protein kinase (AMPK) is a regulator of cellular metabolism in response to changes in the energy status of the cells. AMPK was known to shut down energy-consuming pathways in response to a fall in the ATP/AMP ratio by phosphorylating key enzymes of intermediate metabolism. Here we will discuss the recent evidence implicating AMPK in the regulation of gene expression in mammals, mainly in the liver and in the pancreatic /I-cells.
AMPK was first described as the protein kinase responsible for the phosphorylation and inactivation of 3 -hydroxy-3 -methyl-glutaryl-coenzyme A (HMG-CoA) reductase, the key enzyme of cholesterol synthesis [6] . In 1980, a protein kinase distinct from CAMP-dependent protein kinase, whose activity was dependent on AMP and capable of phosphorylating and thus inhibiting acetyl-CoA carboxylase (ACC), the key enzyme of fatty acid synthesis, was characterized [7] . In 1987 Carling, Zammit and Hardie showed that the HMG-CoA kinase and the ACC kinase were the same enzyme [8] . They also defined its energy sensitive status and described the mechanism of activation of AMPK [l] . AMPK is activated allosterically by AMP and by reversible phosphorylation at residue Thr'" of the a-subunit by an upstream kinase, AMPK kinase, which is also a metabolite-sensing protein kinase and is activated by AMP [l] . Stresses such as heat-shock, hypoxia, and arsenic that cause a rise in the AMP/ATP ratio activate AMPK. Starvation and exercise have also been reported to activate AMPK in the liver [9-111. AMPK is also activated in muscle during contraction b y a decrease in the phosphocreatine/ creatine ratio [ 121. By phosphorylating and inactivating HMG-CoA reductase and ACC, AMPK shuts down cholesterol and fatty acid synthesis, two energy-consuming pathways, and by the inhibition of ACC, it replenishes the A T P stores by promoting fatty acid oxidation via a decrease in malonyl-CoA levels [8, 13] Sucrose non-fermenting-I complex (SNF I ) and glucose repression in yeast Cloning of AMPK has revealed its striking homology with a component of the yeast S N F l complex. S N F l is formed in yeast by the association of Snflp, Snf4p and Sip1 /Sip2/Ga183 proteins and is the key regulator of glucosedependent gene derepression [ 1, 17, 18] . All three subunits of AMPK are related to the proteins forming the S N F l complex in yeast. When glucose is removed from the growth medium of yeast Saccharomyces cerevisiae, a phosphorylation cascade is activated, involving Snflp, which signals glucose absence to the nucleus and switches on the transcription of genes whose products are necessary for the metabolism of alternative carbon sources, such as sucrose, maltose and galactose. Mutants for the SNFl gene are unable to grow in the absence of glucose. T h e homology between AMPK and Snflp has led to the hypothesis that AMPK, in addition to its role in regulating fuel partitioning b y phosphorylation of key enzymes, may also be involved in glucose-dependent gene transcription in mammalian cells. Beginning with studies in 1998 [19, 20] , considerable evidence has now accumulated demonstrating that AMPK is indeed involved in the regulation of gene expression in mammals, at least in liver, pancreatic islet /3-cells and muscle cells [5,19-241. 
AMPK and regulation of gene transcription in mammals Liver gene expression
Glucose is an important regulator of gene expression in the liver. According to glucose availability, different metabolic pathways might be turned on and off to ensure a correct handling of energy supply and the maintenance of normal blood glucose level. Glucose positively regulates the expression of many glycolytic and lipogenic enzymes [25] and negatively regulates the expression of the key gluconeogenic gene that encodes phosphoenolpyruvate carboxykinase (PEPCK) [261. As in yeast, glucose promotes the expression of genes encoding proteins involved in its own metabolism.
It is difficult to distinguish the contribution of increases in the concentration of glucose to the regulation of hepatic genes in vivo, since glucose also provokes insulin secretion and inhibits glucagon secretion. These two hormones have been long known to be important regulators of gene expression, but recently carbohydrates have been shown to play a key role in gene transcription by themselves [25, 27] . Analyses in vitro, using cultured rat or mouse hepatocytes made it possible to distinguish between purely glucose-dependent genes, purely insulin-dependent genes and genes with mixed dependence [28] . T h e glucosesignalling pathway in hepatocytes begins with the entry of glucose via the glucose transporter G L U T 2 , which is bi-directional and allows rapid equilibration between intra-and extra-cellular glucose concentrations [29] . Glucose must then be phosphorylated to glucose 6-phosphate (G6P) by glucokinase (GK) in order to transmit its signal to the transcriptional machinery. T h e hepatic G K gene is now considered as the prototype of a purely ' insulin-dependent ' gene. Insulin induction of G K gene expression is thought to be mediated by the transcription factor sterol response element binding protein l c (SREBPlc) [30] . T h e signalling steps subsequent to the formation of G6P are, however, still disputed. In any case, a phosphorylation/dephosphorylation cascade is apparently activated next in order to transmit the glucose signal to the nucleus [20,3 11. It is now widely accepted that AMPK activation, whether by the use of the pharmacological activator 5-aminoimidazole-4-carboxamide riboside (AICAR) or by the adenoviral gene transfer of a constitutively-active form of the kinase, inhibits the glucose-stimulated transcription of the L-type pyruvate kinase (L-PK), Spot 14, fatty acid synthase (FAS), and ACC genes [19, 20, 22] , and conversely, AICAR stimulates the expression of the glucose-inhibited PEPCK gene [21] . However, it has to be emphasized that conflicting results have been published for the PEPCK gene. As well as a report describing a stimulatory effect of AICAR on PEPCK gene transcription in rat hepatocytes in primary culture [21] , one publication reported no effect of AMPK activation on PEPCK gene expression [ 191 and another reported that AMPK activation by AICAR mimicked insulin action and inhibited PEPCK gene transcription [24] . T h e experimental conditions used by Leclerc, Kahn and Doiron [19] to visualize PEPCK mRNA by Northern blotting included the addition of CAMP in the culture medium of primary hepatocytes. This would have already maximally stimulated PEPCK gene expression and explains why no additional effect of AICAR was detected [21] . On the other hand, it is more difficult to interpret the data presented by Lochhead et al. [24] , suggesting that AMPK activation would mimic the effect of insulin on gluconeogenic gene expression. One possible explanation for the results of Lochhead et al. is that these workers exclusively used a rat hepatoma-derived cell line (H4IIE) in their study. Extreme caution should be taken when working with cell lines, since they very often lose the expression of proteins necessary for the correct regulation of gene expression in response to glucose or insulin [32, 33] .
Attempts were made to inhibit AMPK activity in hepatocytes in primary culture by the use of an adenovirus encoding a dominant negative form of the al-subunit of AMPK ( A d a 1 DN), and to study the resulting effect on the expression of glucose-dependent genes at low glucose concentration [22] . Hepatocytes infected with Ad.alDN did not show any increase in L-PK, Spot 14, FAS or ACC mRNA abundance at low glucose concentration, as one would have expected if, in hepatocytes, AMPK inhibition was the mechanism by which glucose induces the expression of these genes [22] . However, only a partial AMPK inhibition was achieved by the use of Ad.alDN (75 % of the AICAR-stimulated AMPK activity and 60% in the basal state). Unfortunately, no positive control of AMPK inhibition, such as stimulation of ACC activity [7, 8, 34] , was presented.
It is now clear that in hepatocytes in primary culture, AMPIC activation leads to inhibition of the effect of glucose on gene expression [19-221. By contrast, there is no definitive proof of a role for AMPK in the glucose-signalling pathway to gene expression in liver cells. In fact, the presence or absence of glucose in the medium of hepatocytes in primary culture, with or without insulin, does not modify AMPK activity measured in cell homogenates [20, 22] . Interestingly, in the hepatoma cell line mhAT3F [35] , glucose inhibits AMPK activity (I. Leclerc and A. Kahn, unpublished work) , and insulin has a similar effect in the hepatoma cell line Fao [34] . In the whole animal, starvation stimulates AMPK activity in the liver, whereas a carbohydrate-rich diet inhibits it [9, 10] .
T h e precise nutritional modulator of AMPK activity in the liver has yet to be defined.
Conclusive answers concerning the role of AMPK isoforms inhibition on glucose-dependent gene expression in the liver should come from the study of the hepatocytes of knock-out mice for the a l -and a2-subunits of AMPK [36] .
Pancreatic B-cell gene expression
In the pancreatic /?-cell, glucose positively regulates the expression of glycolytic enzymes [37] and preproinsulin (PPI) [38] genes and negatively regulates the expression of the peroxisome proliferator-activated receptor-a gene [39], a transcription factor responsible for the entire programme of fatty acid oxidation. In MIN6 pancreatic islet /?-cells, we have shown that AMPK activation by AICAR inhibited the activities of the L-PK and human PPI promoters at high glucose concentration, whereas microinjection of antibodies directed against the 1x2-subunit of AMPK into the cytosol and the nucleus of single living MIN6 cells stimulated the activity of these promoters at low glucose concentration [ 5 ] . It is significant that microinjection of antibodies directed against the a1 -subunit did not affect promoter activities, while microinjection of antibodies directed against the a2-and /32-subunits, which co-immunoprecipitate both the a1 -and a2-subunits (I. Leclerc, unpublished work) was effective, indicating that the 1x2-containing complexes are those involved in the regulation of gene transcription.
Several factors could explain the discrepancy between the results obtained with Ad.alDN in primary cultured hepatocytes and the microinjection of antibodies against the a2-subunit of AMPK in MIN6 /?-cells. Firstly, the /?-cells used (MIN6) were derived from a mouse insulinoma, and could theoretically respond differently than primary /?-cells. It has long been believed that the glucosesignalling pathway through gene expression was identical in hepatocytes and in /?-cells [37] , but recently this idea has been challenged and it is now accepted that the glucose-signalling pathway differs between the hepatocyte and the /?-cell. In /?-cells, glucose can act by inducing insulin secretion. Thus insulin, and not glucose, is the positive regulator for PPI and L-PK gene expression [40] [41] [42] .
In the pancreatic MIN6, INS1 or HIT-T15 /?-cell lines, stimulatory glucose concentrations (> 8 mM) inhibit AMPK activity [5, 43] . Whether this phenomenon is a specific feature of pancreatic /?-cells, or a more generalized feature of cell lines, is not clearly defined. It is noteworthy that in pancreatic /?-cells, glucose metabolism causes an increase in ATP concentration [44, 45] , and therefore would be expected to have an inhibitory effect on AMPK activity [46] . By contrast, increases in glucose concentration have near detectable effects on A T P levels in the liver [47] .
Gene expression in muscle tissue
AMPK is activated in skeletal muscle after exercise [48] , and promotes contraction-dependent, insulin-independent glucose transport via G L U T 4 translocation to the plasma membrane [49] . T h e molecular confirmation of AMPK in exercise-induced glucose transport has been shown in transgenic mice that over-express dominant negative forms of the kinase [SO] . Exercise is also known to modulate gene expression in muscle tissue, and it has been proposed that this transcriptional effect of exercise may be mediated by AMPK [23, 51] .
Downstream targets of AMPK and gene transcription
In order to determine which transcription factor is involved in the AMPK-signalling pathway to gene expression in hepatocytes, we performed electrophoretic mobility gel shifts assays using elements of the L-PK promoter as DNA probes and nuclear extracts of hepatocytes in primary culture incubated in the presence of AICAR [52] . This resulted in the disappearance of the hepatocyte nuclear factor-4a (HNF4) retarded band. T h e expression of all of the HNF4-dependent genes tested so far was down-regulated when hepatocytes were incubated in the presence of AICAR, whether they were glucose-responsive genes like GLUT2, L-PK and aldolase B, or glucoseunresponsive genes like HNF1, ApoB and ApoCIII [52] . T h e mechanism by which AMPK inhibits H N F 4 function is not completely resolved at the present time, but it seems to occur at the translational or post-translational levels. Concordant with this hypothesis is the fact that AICAR inhibits peptide chain elongation in C H O cells, possibly by phosphorylating eukaryotic elongation factor 2 [53] . H N F 4 in the adult liver is mainly involved in the control of lipid export [54] . By decreasing H N F 4 protein levels, AMPK could decrease apolipoprotein synthesis and stop lipid export from the liver, therefore preserving this carbon source for A T P repletion at the cellular level.
It is likely that AMPK regulates gene expression by interfering with other transcription factors, since the glucose-regulated genes Spot 14, FAS, ACC and PEPCK, whose transcription is controlled by AMPK [19-221, are not strictly HNF4-dependent genes. Other transcription factors involved in the expression of these genes that could be serious candidates for the AMPK inhibitory effect are the insulin-responsive factor SREBPlc [30, 55, 56] and the newly described carbohydrate-responsive factor [57,57a] . It has been shown recently that AMPK phosphorylates the transcriptional co-activator p300 and that this phosphorylation blocks its interaction with nuclear receptors, mainly peroxisome proliferatoractivated receptor y , thyroid receptor, retinoic acid receptor, and retinoid X receptor [58] . Another possibility would be that AMPK acts as a histone-kinase, and has a more generalized effect on transcription, as recently shown for its yeast homologue, Snfl p [ 591.
Conclusion
T h e mammalian AMPK complex is emerging as an exciting new signal transduction molecule, with an important role in the nutritional regulation of gene expression. As such, the enzyme may represent an exciting new therapeutic target for metabolic disorders, including diabetes mellitus. 
